Similar articles for PMID: 24191934

Year	Number of Results
2007	2
2009	2
2010	3
2011	4
2012	3
2013	9
2014	6
2015	4
2016	16
2017	19
2018	13
2019	14
2020	6
2021	7
2022	1

1

Opportunities to exploit non-neutralizing HIV-specific antibody activity.

Ackerman ME, Alter G. Ackerman ME, et al. Curr HIV Res. 2013 Jul;11(5):365-77. doi: 10.2174/1570162x113116660058. Curr HIV Res. 2013. PMID: 24191934 Free PMC article. Review.

2

Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.

Lewis GK. Lewis GK. Curr HIV Res. 2013 Jul;11(5):354-64. doi: 10.2174/1570162x113116660060. Curr HIV Res. 2013. PMID: 24191940 Review.

3

Editorial: Fc receptor-mediated effector functions in the humoral control of HIV-1 infection.

DeVico A. DeVico A. Curr HIV Res. 2013 Jul;11(5):343-4. doi: 10.2174/1570162x113116660056. Curr HIV Res. 2013. PMID: 24191941 No abstract available.

4

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.

Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME. Brown EP, et al. J Immunol Methods. 2017 Apr;443:33-44. doi: 10.1016/j.jim.2017.01.010. Epub 2017 Feb 3. J Immunol Methods. 2017. PMID: 28163018 Free PMC article.

5

Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.

Su B, Dispinseri S, Iannone V, Zhang T, Wu H, Carapito R, Bahram S, Scarlatti G, Moog C. Su B, et al. Front Immunol. 2019 Dec 18;10:2968. doi: 10.3389/fimmu.2019.02968. eCollection 2019. Front Immunol. 2019. PMID: 31921207 Free PMC article. Review.

6

HIV-specific antibody immunity mediated through NK cells and monocytes.

Kramski M, Parsons MS, Stratov I, Kent SJ. Kramski M, et al. Curr HIV Res. 2013 Jul;11(5):388-406. doi: 10.2174/1570162x113116660061. Curr HIV Res. 2013. PMID: 24191935 Review.

7

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.

Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim S, Moore PL, Ackerman ME, Alter G, Morris L. Richardson SI, et al. PLoS Pathog. 2018 Apr 9;14(4):e1006987. doi: 10.1371/journal.ppat.1006987. eCollection 2018 Apr. PLoS Pathog. 2018. PMID: 29630668 Free PMC article.

8

Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Vargas-Inchaustegui DA, Robert-Guroff M. Vargas-Inchaustegui DA, et al. Curr HIV Res. 2013 Jul;11(5):407-20. doi: 10.2174/1570162x113116660063. Curr HIV Res. 2013. PMID: 24191937 Free PMC article.

9

VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.

Smith SA, Burton SL, Kilembe W, Lakhi S, Karita E, Price M, Allen S, Derdeyn CA. Smith SA, et al. Front Immunol. 2019 Jan 15;9:3163. doi: 10.3389/fimmu.2018.03163. eCollection 2018. Front Immunol. 2019. PMID: 30697215 Free PMC article.

10

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination.

Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, Streeck H, Pau M, Schuitemaker H, Francis D, Fast P, Laufer D, Walker BD, Baden L, Barouch DH, Alter G. Mahan AE, et al. PLoS Pathog. 2016 Mar 16;12(3):e1005456. doi: 10.1371/journal.ppat.1005456. eCollection 2016 Mar. PLoS Pathog. 2016. PMID: 26982805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed